ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

XGN Exagen Inc

5.02
0.07 (1.41%)
24 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Exagen Inc NASDAQ:XGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 1.41% 5.02 4.65 5.60 5.30 4.68 5.10 65,825 22:00:00

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

13/11/2024 9:05pm

GlobeNewswire Inc.


Exagen (NASDAQ:XGN)
Historical Stock Chart


From Oct 2024 to Dec 2024

Click Here for more Exagen Charts.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following upcoming investor conferences:

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Company presentation by John Aballi, President and CEO on Thursday, November 21, 2024, at 3:00 p.m. EST at the Westin NY Grand Central Hotel. Management will also participate in one-on-one investor meetings.

Evercore HEALTHCONx Conference

Company presentation by John Aballi, President and CEO on Wednesday, December 4, 2024, at 12:30 p.m. EST at The Lowes Coral Gables Hotel in Coral Gables, FL. Management will also participate in one-on-one investor meetings.

TD Cowen Diagnosing Tomorrow Conference – Tools and Technologies for the Next Decade

John Aballi, President and CEO, with participate in a panel discussion titled: Beyond Cancer on Thursday, December 12, 2024, at 2:40 p.m. EST at One Vanderbilt, 20th Floor, New York, NY.

About Exagen Inc.

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, Calif., Exagen’s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s syndrome earlier and with greater accuracy. Exagen’s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management. For more information, visit Exagen.com or follow @ExagenInc on X.

Exagen Inc.Ryan DouglasIR@exagen.com760.560.1525

1 Year Exagen Chart

1 Year Exagen Chart

1 Month Exagen Chart

1 Month Exagen Chart

Your Recent History

Delayed Upgrade Clock